Deborah Sterling,
Director
Dr. Sterling is a Director in the Biotechnology/Chemical Group. Her practice is focused in the biotechnology and pharmaceutical industries, where she is involved in all areas of patent procurement, exploitation and enforcement. Dr. Sterling’s experience includes representing clients in approximately 45 inter partes review proceedings, and in multiple patent interferences and reexaminations. Dr. Sterling’s practice also includes counseling clients on intellectual property strategy, including evaluating patent portfolios, e.g., for invalidity, non-infringement, freedom-to-operate and due diligence analyses, and she has assisted clients in devising design-around strategies for issued patents. She has also been involved in multiple pharmaceutical and biotechnology patent litigations. Dr. Sterling's intellectual property experience has been principally in technical areas such as biotechnology, pharmaceuticals, molecular biology, analytical instruments, agrochemicals, and clean technology. She has been recognized by Corporate LiveWire and was named Biotechnology Lawyer of the Year, Washington, D.C. for her work.
|
|
|
